scholarly journals Successful Treatment of Intrathecal Methotrexate Overdose by Using Ventriculolumbar Perfusion and Intrathecal Instillation of Carboxypeptidase G2

1996 ◽  
Vol 71 (2) ◽  
pp. 161-165 ◽  
Author(s):  
Aengus S. O'Marcaigh ◽  
Christopher M. Johnson ◽  
William A. Smithson ◽  
Marc C. Patterson ◽  
Brigitte C. Widemann ◽  
...  
2007 ◽  
Vol 88 (7) ◽  
pp. 780-782 ◽  
Author(s):  
L Riva ◽  
V Conter ◽  
C Rizzari ◽  
M Jankovic ◽  
A Sala ◽  
...  

1991 ◽  
Vol 9 (4) ◽  
pp. 670-674 ◽  
Author(s):  
P C Adamson ◽  
F M Balis ◽  
C L McCully ◽  
K S Godwin ◽  
J D Bacher ◽  
...  

The carboxypeptidase G class of enzymes rapidly hydrolyze methotrexate (MTX) into the inactive metabolites 4-deoxy-4-amino-N10-methylpteroic acid (DAMPA) and glutamate. This study evaluated the use of carboxypeptidase-G2 (CPDG2) as a potential intrathecal (IT) rescue agent for massive IT MTX overdose. The CSF pharmacokinetics of MTX with and without CPDG2 rescue was studied in adult rhesus monkeys (Macaca mulatta) using a nontoxic IT 5 mg dose (equivalent to 50 mg in humans). Without CPDG2 rescue, peak CSF MTX concentration was 2,904 +/- 340 mumol/L. Within 5 minutes of administration of 30 U IT CPDG2, CSF MTX concentrations decreased greater than 400-fold to 6.55 +/- 6.7 microM. Subsequently, groups of three monkeys received either 25 mg IT MTX (equivalent to 250 mg in humans) followed by 150 U IT CPDG2 or 50 mg IT MTX (equivalent to 500 mg in humans) followed by 300 U IT CPDG2. All animals survived without neurotoxicity. Our studies suggest that CPDG2 may prove to be an important addition to the currently recommended strategy for the management of IT MTX overdose.


2004 ◽  
Vol 96 (20) ◽  
pp. 1557-1559 ◽  
Author(s):  
B. C. Widemann ◽  
F. M. Balis ◽  
A. Shalabi ◽  
M. Boron ◽  
M. O'Brien ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document